HRZN · Categories · M&A
HRZN - Mergers and acquisitions
Horizon Technology Finance Corporation (HRZN) mergers and acquisitions - real-time wire coverage filtered to M&A only.
Recent M&A for HRZN
- BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.VANCOUVER, BC, Feb. 21, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE:BIOV) (FRA: 5LB) (OTCQB:BVAXF) ("BioVaxys" or "Company") is pleased to announce has completed the acquisition of the entire portfolio of discovery, preclinical and clinical development stage assets of former Canadian biotechnology company, IMV Inc., Immunovaccine Technologies Inc., and IMV USA ("IMV"). On February 11th, 2024, the Company executed the definitive Asset Purchase Agreement for the extensive technology portfolio from HIMV, LLC, an acquisition vehicle formed by Horizon Technology Finance Corporation (NASDAQ:HRZN) and IMV's other secured creditors for the purpose of acquiring IMV's intellectual property t
- BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.VANCOUVER, BC, Feb. 12, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE:BIOV) (FRA: 5LB) (OTCQB:BVAXF) ("BioVaxys" or "Company") announced that it has executed the definitive Asset Purchase Agreement dated February 11th, 2024 to acquire the entire portfolio of discovery, preclinical and clinical development stage assets in oncology, infectious disease, antigen desensitization, and other immunological fields based on the DPX™ immune educating platform technology, developed by Canadian biotechnology company, IMV Inc., Immunovaccine Technologies Inc., and IMV USA ("IMV"). BioVaxys acquired the extensive technology portfolio from HIMV, LLC, an acquisition vehicle formed by Horizon Technolo
- Monroe Capital Completes Acquisition of Horizon Technology Finance Management and Expands into Venture DebtMonroe Capital LLC ("Monroe") today announced it has completed the acquisition of Horizon Technology Finance Management LLC ("Horizon"), a market leader in venture debt lending. Horizon is the investment adviser to Horizon Technology Finance Corporation (NASDAQ:HRZN). Horizon is a leading investment manager of venture debt products for high-growth companies in the technology, life sciences, healthcare information and services, and sustainability industries. As a pioneer in venture debt, since its founding in 2004, Horizon has invested in more than 315 venture-backed companies. The acquisition of Horizon augments Monroe Capital's existing platform with an experienced investment team and di